• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依卡替班作为治疗危及生命的阿替普酶诱导的血管性水肿的潜在疗法。

Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.

作者信息

Cheong Edmund, Dodd Lizzie, Smith William, Kleinig Timothy

机构信息

Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Neurology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

出版信息

J Stroke Cerebrovasc Dis. 2018 Feb;27(2):e36-e37. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.039. Epub 2017 Oct 31.

DOI:10.1016/j.jstrokecerebrovasdis.2017.09.039
PMID:29097062
Abstract

Severe orolingual angioedema is a life-threatening complication of alteplase treatment for acute ischemic stroke that occurs during alteplase infusion or in the first 2 hours afterward. Currently, there are no proven therapies, although glucocorticoids, antihistamines, and adrenaline are sometimes used. Intubation is required if significant airway compromise supervenes. The incidence is .2%-5.1%, and risk factors include treatment with angiotensin-converting enzyme inhibitors and total insular infarcts. Here we report a case of alteplase-induced severe angioedema, which resolved briskly following icatibant treatment.

摘要

严重口咽血管性水肿是急性缺血性卒中阿替普酶治疗的一种危及生命的并发症,发生于阿替普酶输注期间或之后的2小时内。目前,尚无经证实的治疗方法,尽管有时会使用糖皮质激素、抗组胺药和肾上腺素。如果出现严重气道受压,则需要插管。发病率为0.2% - 5.1%,危险因素包括使用血管紧张素转换酶抑制剂治疗和岛叶完全梗死。我们在此报告1例阿替普酶诱导的严重血管性水肿病例,该病例在接受依卡替班治疗后迅速缓解。

相似文献

1
Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.依卡替班作为治疗危及生命的阿替普酶诱导的血管性水肿的潜在疗法。
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):e36-e37. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.039. Epub 2017 Oct 31.
2
Icatibant averting mechanical ventilation in acute ischemic stroke patient with alteplase-induced orolingual angioedema.艾替班特可避免急性缺血性卒中患者因阿替普酶诱发的口咽血管性水肿而进行机械通气。
Eur J Neurol. 2024 Apr;31(4):e16173. doi: 10.1111/ene.16173. Epub 2023 Dec 28.
3
[Treatment of alteplase-induced orolingual angioedema by means of icatibant].[依卡替班治疗阿替普酶诱发的口咽血管性水肿]
Rev Neurol. 2019 Sep 16;69(6):261-262. doi: 10.33588/rn.6906.2019123.
4
Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.依卡替班治疗血管紧张素转换酶(ACE)抑制剂相关性血管性水肿。
Intern Med J. 2015 Aug;45(8):821-7. doi: 10.1111/imj.12799.
5
Alteplase associated Orolingual angioedema: A case report and literature review.阿替普酶相关的口-舌血管性水肿:病例报告及文献复习。
Medicine (Baltimore). 2022 Dec 30;101(52):e32474. doi: 10.1097/MD.0000000000032474.
6
Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker.一名服用血管紧张素 II 受体阻滞剂的患者溶栓后出现半侧舌部血管性水肿。
J Stroke Cerebrovasc Dis. 2019 May;28(5):e44-e45. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.030. Epub 2019 Feb 13.
7
The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.依卡替班(一种B2缓激肽受体拮抗剂)在急诊科危及生命的喉血管性水肿中的作用。
Am J Emerg Med. 2015 Mar;33(3):479.e1-3. doi: 10.1016/j.ajem.2014.08.055. Epub 2014 Aug 27.
8
A randomized trial of icatibant in ACE-inhibitor-induced angioedema.依替巴肽治疗血管性水肿的随机试验。
N Engl J Med. 2015 Jan 29;372(5):418-25. doi: 10.1056/NEJMoa1312524.
9
Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.急性缺血性脑卒中阿替普酶治疗后口腔-舌血管性水肿:发生率及血管紧张素转换酶抑制剂使用史的风险。
Eur J Neurol. 2014 Oct;21(10):1285-91. doi: 10.1111/ene.12472. Epub 2014 Jun 9.
10
Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal.急性卒中阿替普酶治疗相关的口咽血管性水肿:重新评估
J Stroke Cerebrovasc Dis. 2015 Jan;24(1):31-40. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.045. Epub 2014 Nov 12.

引用本文的文献

1
Bradykinin-Mediated Angioedema Induced by Drugs.药物诱导的缓激肽介导的血管性水肿
J Clin Med. 2025 Aug 12;14(16):5712. doi: 10.3390/jcm14165712.
2
Icatibant averting mechanical ventilation in acute ischemic stroke patient with alteplase-induced orolingual angioedema.艾替班特可避免急性缺血性卒中患者因阿替普酶诱发的口咽血管性水肿而进行机械通气。
Eur J Neurol. 2024 Apr;31(4):e16173. doi: 10.1111/ene.16173. Epub 2023 Dec 28.
3
Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.缓激肽介导的血管性水肿的神经和精神表现:旧的和新的挑战。
Int J Mol Sci. 2023 Jul 29;24(15):12184. doi: 10.3390/ijms241512184.
4
Therapeutic effects of alteplase intravenous thrombolysis on different types of acute cerebral infarction: a controlled randomized analysis.阿替普酶静脉溶栓对不同类型急性脑梗死的治疗效果:一项对照随机分析
Am J Transl Res. 2021 Aug 15;13(8):9129-9135. eCollection 2021.
5
Unilateral orolingual angioedema in a patient with sarcoidosis after intravenous thrombolysis due to acute stroke without improvement after treatment with icatibant.一名结节病患者在因急性中风接受静脉溶栓治疗后出现单侧口面部血管性水肿,伊曲班坦治疗后无改善。
BMJ Case Rep. 2020 Dec 21;13(12):e236643. doi: 10.1136/bcr-2020-236643.
6
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.缓激肽及其代谢产物分解受损可能是新冠病毒感染导致肺水肿的原因
Semin Thromb Hemost. 2020 Oct;46(7):835-837. doi: 10.1055/s-0040-1712960. Epub 2020 Jun 11.
7
Incidence of orolingual angioedema after intravenous thrombolysis for stroke.静脉溶栓治疗卒中后口咽血管性水肿的发生率。
Neurol Sci. 2018 Nov;39(11):1877-1879. doi: 10.1007/s10072-018-3512-1. Epub 2018 Aug 6.